MAD2L2 and clear cell adenocarcinoma: They thus arrived at the conclusion that immunohistochemical staining for REV-7 is a good tissue marker for predicting chemosensitivity, while at the same time, REV-7 protein represents a potential molecular target for the management of clear cell carcinomas [12].